Global Rabies Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Rabies Diagnostics Market is presumed to reach the market size of nearly USD 8.05 BN by 2030 from USD 4.56 BN in 2022 with a CAGR of 6.52% under the study period 2023 - 2030.

Rabies is an acute viral infection that typically infects the neurological system. The causative agent of rabies is rhabdovirus, which is generally spread via the bite of a rabid animal. The most popularly known rabies diagnostic methods include Fluorescent Antibody Test (FAT), immunohistochemical tests, Direct Fluorescent Antibody (DFA) tests, and amplification methods. A direct fluorescent antibody (DFA) test can be used to diagnose rabies in animals and can find the presence of rabies viral antigens in brain tissue. However, several tests are necessary for humans.

MARKET DYNAMICS:

The increasing prevalence of neglected tropical diseases (NTDs) will be a crucial factor in boosting the growth rate of the rabies diagnostics market. Furthermore, the incidences of rabies will rise as dog bite instances rise, which will positively drive the market's growth rate. The increase in laws related to rabies diagnosis is a crucial factor contributing to the market's growth. In addition, rising healthcare expenditure and public awareness regarding the fatality of viral exposure are the main factors that will support market growth. Additionally, the expansion of organization-to-organization collaborations for the creation of novel products and the development of rabies research will favorably influence the development of the rabies diagnostics market. The increasing adoption of advanced technology for rabies care and diagnostic solutions worldwide is another major factor propelling the market growth for rabies diagnostics.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of rabies diagnostics. The growth and trends of rabies diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the rabies diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Diagnostic Method

Fluorescent Antibody Test (FAT)
Immunohistochemical Test
Amplification Methods
Histologic Examination
Serology Tests

By Technology Method

ELISA/Immunohistochemistry
Chromatography Techniques
PCR
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Rabies Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the rabies diagnostics market include Bio-Rad Laboratories Inc., Aviva Systems Biology Corporation, Merck KGaA, Demeditec Diagnostics GmbH, Creative Diagnostics, Norgen Biotek Corp., Abbexa Ltd., Express Biotech International Inc., BioNote Inc., MyBioSource.com. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11219365

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . RABIES DIAGNOSTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Diagnostic Method
- 3.7.2 Market Attractiveness Analysis By Technology Method
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL RABIES DIAGNOSTICS MARKET ANALYSIS BY DIAGNOSTIC METHOD

6.1 Overview by Diagnostic Method
6.2 Historical and Forecast Data
6.3 Analysis by Diagnostic Method
6.4 Fluorescent Antibody Test (FAT) Historic and Forecast Sales by Regions
6.5 Immunohistochemical Test Historic and Forecast Sales by Regions
6.6 Amplification Methods Historic and Forecast Sales by Regions
6.7 Histologic Examination Historic and Forecast Sales by Regions
6.8 Serology Tests Historic and Forecast Sales by Regions

7 . GLOBAL RABIES DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY METHOD

7.1 Overview by Technology Method
7.2 Historical and Forecast Data
7.3 Analysis by Technology Method
7.4 ELISA/Immunohistochemistry Historic and Forecast Sales by Regions
7.5 Chromatography Techniques Historic and Forecast Sales by Regions
7.6 PCR Historic and Forecast Sales by Regions
7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL RABIES DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE RABIES DIAGNOSTICS COMPANIES

9.1. Rabies Diagnostics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF RABIES DIAGNOSTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Bio-Rad Laboratories Inc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Aviva Systems Biology Corporation
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Merck KGaA
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Demeditec Diagnostics GmbH
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Creative Diagnostics
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Norgen Biotek Corp.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Abbexa Ltd.
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Express Biotech International Inc.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. BioNote Inc.
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. MyBioSource.com.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies